ARTICLE | Company News
Response Biomedical, Nippon Kayaku deal
February 20, 2001 8:00 AM UTC
The companies will develop a point-of-care diagnostic for prostate specific antigen using RBM’s Rapid Antigen Measurement Platform (RAMP). Nippon Kayaku will fund development and Japanese regulatory a...